Wealthcare Advisory Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Sell
3,618
-1,744
-33% -$153K 0.01% 839
2026
Q1
$457K Buy
5,362
+649
+14% +$57.8K 0.01% 726
2025
Q4
$372K Buy
4,713
+263
+6% +$20.6K 0.01% 791
2025
Q3
$356K Buy
4,450
+152
+4% +$13K 0.01% 785
2025
Q2
$391K Sell
4,298
-113
-3% -$10.3K 0.01% 712
2025
Q1
$413K Buy
4,411
+402
+10% +$36K 0.01% 635
2024
Q4
$364K Buy
4,009
+162
+4% +$15.5K 0.01% 651
2024
Q3
$399K Sell
3,847
-98
-2% -$9.99K 0.01% 625
2024
Q2
$383K Buy
3,945
+445
+13% +$41K 0.01% 600
2024
Q1
$315K Buy
3,500
+96
+3% +$8.13K 0.01% 653
2023
Q4
$271K Buy
3,404
+127
+4% +$9.55K 0.01% 631
2023
Q3
$233K Buy
3,277
+27
+0.8% +$2.02K 0.01% 613
2023
Q2
$250K Buy
3,250
+96
+3% +$7.43K 0.01% 619
2023
Q1
$237K Buy
3,154
+406
+15% +$30.2K 0.01% 649
2022
Q4
$217K Buy
+2,748
New +$206K 0.01% 636
2021
Q2
Sell
-2,696
Closed -$213K 781
2021
Q1
$213K Buy
+2,696
New +$211K 0.02% 471
2020
Q2
Sell
-1,328
Closed -$88K 492
2020
Q1
$88K Buy
1,328
+40
+3% +$2.82K 0.01% 397
2019
Q4
$89K Hold
1,288
0.01% 424
2019
Q3
$95K Buy
1,288
+101
+9% +$7.33K 0.01% 402
2019
Q2
$85K Hold
1,187
0.01% 410
2019
Q1
$81K Hold
1,187
0.01% 376
2018
Q4
$71K Sell
1,187
-17
-1% -$1.06K 0.01% 365
2018
Q3
$81K Hold
1,204
0.01% 371
2018
Q2
$78K Buy
1,204
+17
+1% +$1.11K 0.02% 375
2018
Q1
$85K Sell
1,187
-79
-6% -$5.68K 0.02% 307
2017
Q4
$96K Buy
1,266
+920
+266% +$67.2K 0.02% 260
2017
Q3
$25K Buy
+346
New +$24.9K 0.01% 392

Other funds holding CL

Wealthcare Advisory Partners's CL Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its Colgate-Palmolive (CL) stake by 33% in Q2 2026, selling an estimated $153K and leaving 3,618 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #839.

Wealthcare Advisory Partners first reported a position in CL in Q3 2017 and has held it in 27 quarters since. The position peaked at $457K in Q1 2026. 645 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Wealthcare Advisory Partners held 3,618 shares of Colgate-Palmolive worth $332K as of Q2 2026.
  • Wealthcare Advisory Partners sold 1,744 Colgate-Palmolive shares in Q2 2026, an estimated $153K.
  • Colgate-Palmolive made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #839 holding.
  • Wealthcare Advisory Partners first reported a position in Colgate-Palmolive in Q3 2017 and has held it in 27 quarters since.
  • Wealthcare Advisory Partners's Colgate-Palmolive position peaked at $457K in Q1 2026.
  • 645 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.